Target intelligence / Profile preview

Voltage-gated potassium channel subunit Kv1.3 (Kv1.3)

Target
Kv1.3
Molecular classification
Ion channel, Voltage-gated potassium channel
01

Overview

Kv1.3 (Voltage-gated potassium channel subunit Kv1.3), encoded by the KCNA3 gene, is a member of the voltage-gated potassium (Kv) channel family. It plays a critical role in regulating membrane potential and cellular excitability, particularly in immune cells such as T lymphocytes. It is a tetramer composed of four α-subunits, each with six transmembrane helices. Kv1.3 mediates outward K+ efflux upon membrane depolarization and is essential for repolarization during action potentials. In immune cells, it regulates calcium signaling required for activation, proliferation, and cytokine production. Kv1.3 is expressed in the immune system, nervous system, and other tissues. Overexpression or hyperactivity is linked to autoimmune diseases, while mitochondrial/nuclear Kv1.3 is implicated in apoptosis regulation in cancer. Kv1.3 is an attractive target for immunomodulatory therapies, and structural studies have elucidated mechanisms of inhibition using nanobodies or antibody-toxin fusions.

Other names
KCNA3HGK5
02

Mechanism of action

Inhibition of potassium ion flow through the Kv1.3 channel, either by inducing inactive conformation or physically blocking the pore.

03

Biological functions

Membrane repolarizationRegulation of calcium signalingRegulation of membrane potentialCellular excitability
04

Disease associations

Autoimmune diseasesMultiple sclerosisRheumatoid arthritisCancer
05

Safety considerations

Potential for broad immunosuppression if not targeted specifically.Off-target effects on other potassium channels.

Beyond the preview

Go deeper on Voltage-gated potassium channel subunit Kv1.3 (Kv1.3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-gated potassium channel subunit Kv1.3 (Kv1.3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call